Marek's Disease Virus-Encoded vIL-8 Gene Is Involved in Early Cytolytic Infection but Dispensable for Establishment of Latency

Journal of Virology

Volumn 78, Issue 9, 2004, Pages 4753-4760

  Cui, Xiaoping ^a   Lee, Lucy F ^b   Reed, Willie M ^a   Kung, Hsing Jien ^c   Reddy, Sanjay M ^b,d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; ASPARTIC ACID; GENE PRODUCT; GLUTAMIC ACID; LEUCINE; LYSINE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CELL CULTURE; CHICKEN; CYTOLYSIS; DISEASE MODEL; GENE; GENE DELETION; GENE FUNCTION; LATENT PERIOD; LONG TERMINAL REPEAT; LYMPHOID ORGAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; SEQUENCE HOMOLOGY; TUMOR; VIL 8 GENE; VIREMIA; VIRUS GENOME; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; CHICKENS; FEMALE; GENE DELETION; HERPESVIRUS 2, GALLID; INTERLEUKIN-8; LYMPHOID TISSUE; MALE; MAREK DISEASE; POULTRY DISEASES; RECOMBINATION, GENETIC; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 4143090064     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.9.4753-4760.2004     Document Type: Article

References (36)

1. Afonso, C. L., E. R. Tulman, Z. Lu, L. Zsak, D. L. Rock, and G. F. Kutish. 2001. The genome of turkey herpesvirus. J. Virol. 75:971-978.
2. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675-705.
3. Becker, Y., Y. Asher, E. Tabor, I. Davidson, M. Malkinson, and Y. Weisman. 1992. Polymerase chain reaction for differentiation between pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDV) and vaccine viruses of MDV-serotypes 2 and 3. J. Virol. Methods 40:307-322.
4. Biggs, P. M. 1975. Marek's disease-the disease and its prevention by vaccination. Br. J. Cancer 31(Suppl. 2):152-155.
5. Buckmaster, A. E., S. D. Scott, M. J. Sanderson, M. E. Boursnell, N. L. Ross, and M. M. Binns. 1988. Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification, J. Gen. Virol. 69:2033-2042.
6. Bülow, V., and P. M. Biggs. 1975. Differentiation between strains of Marek's disease. Avian Pathol. 6:395-403.
7. Calnek, B., and R. L. Witter. 1997. Neoplastic diseases: Marek's disease, p. 369-413. In B. Calnek (ed.), Disease of poultry, 10th ed. Iowa State University Press, Ames, Iowa.
8. Calnek, B. W. 1972. Effects of passive antibody on early pathogenesis of Marek's disease. Infect. Immun. 6:193-198.
9. Calnek, B. W., J. C. Carlisle, J. Fabricant, K. K. Murthy, and K. A. Schat. 1979. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. Am. J. Vet. Res. 40.541-548.
10. Calnek, B. W., K. A. Schat, M. C. Peckham, and J. Fabricant. 1983. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Dis. 27:844-849.
11. Calnek, B. W., W. R. Shek, and K. A. Schat. 1981. Latent infections with Marek's disease virus and turkey herpesvirus. J. Natl. Cancer Inst. 66:585-590.
12. Cohen, J. I., and K. E. Seidel. 1993. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro, Proc. Natl. Acad. Sci. USA 90:7376-7380.
13. Cui, Z. Z., L. F. Lee, E. J. Smith, R. L. Witter, and T. S. Chang. 1988. Monoclonal-antibody-mediated enzyme-linked immunosorbent assay for detection of reticuloendotheliosis viruses. Avian Dis. 32:32-40.
14. Cui, Z. Z., D. Yan, and L. F. Lee. 1990. Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins. Virus Genes 3:309-322.
15. Ferrin, L. J., and R. D. Camerini-Otero. 1991. Selective cleavage of human DNA: RecA-assisted restriction endonuclease (RARE) cleavage. Science 254:1494-1497.
16. Izumiya, Y., H. K. Jang, M. Ono, and T. Mikami. 2001. A complete genomic DNA sequence of Marek's disease virus type 2, strain HPRS24. Curr. Top. Microbiol. Immunol. 255:191-221.
17. Kaaden, O. R., A. Scholz, A. Ben-Zeev, and Y. Becker. 1977. Isolation of Marek's disease virus DNA from infected cells by electrophoresis on polyacrylamide gels. Arch. Virol. 54:75-83.
18. Lee, L. F., X. Liu, and R. L. Witter. 1983. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J. Immunol. 130:1003-1006.
19. Lee, L. F., P. Wu, D. Sui, D. Ren, J. Kamil, H. J. Kung, and R. L. Witter. 2000. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc. Natl. Acad. Sci. USA 97:6091-6096.
20. Liu, J. L., S. F. Lin, L. Xia, P. Brunovskis, D. Li, I. Davidson, L. F. Lee, and H. J. Kung. 1999. MEQ and V-IL8: cellular genes in disguise? Acta Virol. 43:94-101.
21. Lupiani, B., L. F. Lee, and S. M. Reddy. 2001. Protein-coding content of the sequence of Marek's disease virus serotype 1. Curr. Top. Microbiol. Immunol. 255:159-190.
22. Martins-Green, M. 2001. The chicken chemotactic and angiogenic factor (cCAF), a CXC chemokine. Int. J. Biochem. Cell Biol. 33:427-432.
23. Martins-Green, M., and T. Kelly. 1998. The chicken chemotactic and angiogenic factor (9E3 gene product): its angiogenic properties reside in the C-terminus of the molecule. Cytokine 10:819-830.
24. McGeoch, D. 1989. The genomes of the human herpesviruses: contents, relationships, and evolution. Annu. Rev. Microbiol. 43:235-265.
25. Morgan, R. W., J. L. Cantello, and C. H. McDermot. 1990. Transfection of chicken embryo fibroblasts with Marek's disease virus DNA. Avian Dis. 34:345-351.
26. Parcells, M. S., S.-F. Lin, R. L. Dienglewicz, V. Majerciak, D. R. Robinson, H.-C. Chen, Z. Wu, G. R. Dubyak, P. Brunovskis, H. D. Hunt, L. F. Lee, and H.-J. Kung. 2001. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75:5159-5173.
27. Payne, L. N., and M. Rennie. 1973. Pathogenesis of Marek's disease in chicks with and without maternal antibody. J. Natl. Cancer Inst. 51:1559-1573.
28. Penfold, M. E., D. J. Dairaghi, G. M. Duke, N. Saederup, E. S. Mocarski, G. W. Kemble, and T. J. Schall. 1999. Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. USA 96:9839-9844.
29. Reddy, S. M., B. Lupiani, I. M. Gimeno, R. F. Silva, L. F. Lee, and R. L. Witter. 2002. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl. Acad. Sci. USA 99:7054-7059.
30. Silva, R. F., L. F. Lee, and G. F. Kutish. 2001. The genomic structure of Marek's disease virus. Curr. Top. Microbiol. Immunol. 255:143-158.
31. Strieter, R. M., P. J. Polverini, D. A. Arenberg, and S. L. Kunkel. 1995. The role of CXC chemokines as regulators of angiogenesis. Shock 4:155-160.
32. Tulman, E. R., C. L. Afonso, Z. Lu, L. Zsak, D. L. Rock, and G. F. Kutish. 2000. The genome of a very virulent Marek's disease virus. J. Virol. 74:7980-7988.
33. Witter, R., J. M. Sharma, and A. M. Fadly. 1980. Pathogenicity of variant Marek's disease virus isolants in vaccinated and unvaccinated chickens. Avian Dis. 24:210-232.
34. Witter, R. L. 1991. Attenuated revertant serotype 1 Marek's disease viruses: safety and protective efficacy. Avian Dis. 35:877-891.
35. Witter, R. L. 2001. Protective efficacy of Marek's disease vaccines. Curr. Top. Microbiol. Immunol. 255:57-90.
36. Xing, Z., and K. A. Schat. 2000. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology 100:70-76.